SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLOOK.L Regulatory News (LOOK)

  • There is currently no data for LOOK

Update on offer

20 Jul 2023 08:57

RNS Number : 6538G
Lookers PLC
20 July 2023
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. WITH THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

FOR IMMEDIATE RELEASE

20 July 2023

 

Lookers plc

 

("Lookers" or "the Company")

 

Update on offer

 

Further to this morning's announcements that Cinch Holdco UK Limited ("Cinch") intends to vote against the Acquisition and that Lookers was re-engaging with other shareholders to understand whether the resolutions required to effect the Scheme of Arrangement in order to implement the Acquisition (the "Resolutions") are capable of being passed, the Lookers Directors now believe that shareholders representing in excess of 25% of the voting rights of the Company intend to vote against the Resolutions and therefore that the Resolutions are not capable of being passed.

 

The Court Meeting and General Meeting convened in connection with the Acquisition are scheduled to take place on 27 July 2023. In the event that the Resolutions do not pass, as the Lookers Directors now expect, the Scheme of Arrangement will lapse and Lookers will remain an independent listed company. In this event, the Lookers Directors will continue to pursue constructive engagement with all shareholders, including Cinch, who continues to be the Company's largest shareholder holding approximately 19.52% of the issued share capital.

 

As stated in the Scheme Document, the Lookers Directors remain confident in the future prospects of Lookers to create sustainable value for all stakeholders.

 

A further announcement will be made in due course, as appropriate.

 

Unless the context provides otherwise, words and expressions defined in the Scheme Document shall have the same meanings in this announcement.

 

Enquiries:

 

Lookers plc

Mark Raban, Chief Executive Officer

Oliver Laird, Chief Financial Officer

via MHP

 

Numis Securities Limited (Joint Financial Adviser and Corporate Broker to Lookers)

Stuart Dickson

Stuart Ord

Oliver Steele

Duncan Wilson

 +44 (0) 207 260 1000

 

Peel Hunt LLP (Joint Financial Adviser and Corporate Broker to Lookers)

Adrian Trimmings

+44 (0) 207 418 8900

Michael Nicholson

Andrew Clark

Edward Lowe

MHP (Financial PR to Lookers)

Alan Tovey

Tim Rowntree

Charles Hirst

+44 (0) 7833 437 044 /

+44 (0) 20 3128 8193

Lookers@mhpgroup.com

 

Important Notices

Numis Securities Limited ("Numis"), which is authorised and regulated by the FCA in the United Kingdom, is acting exclusively for Lookers and for no one else in connection with the Offer and/or any other matter referred to in this Announcement and will not be responsible to anyone other than Lookers for providing the protections afforded to its clients or for providing advice in relation to the Offer, the contents of this Announcement, or any other matters referred to in this Announcement. Neither Numis nor any of its subsidiaries, affiliates or branches owes or accepts any duty, liability or responsibility whatsoever (whether direct, indirect, consequential, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Numis in connection with this Announcement, any statement or other matter or arrangement referred to herein or otherwise.

Peel Hunt LLP ("Peel Hunt"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for Lookers and for no one else in connection with the matters referred to in this Announcement. Peel Hunt will not be responsible to anyone other than Lookers for providing the protections afforded to clients of Peel Hunt nor for providing advice in relation to the contents of, or matters referred to in, this Announcement. Neither Peel Hunt nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Peel Hunt in connection with the matters referred to in this Announcement, or otherwise.

END

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OUPGRGDRUUDDGXG
Date   Source Headline
18th May 20232:32 pmRNSTransaction in Own Shares
16th May 20235:05 pmRNSTransaction in Own Shares
15th May 20234:44 pmRNSTransaction in Own Shares
12th May 20232:39 pmRNSTransaction in Own Shares
11th May 202311:55 amRNSTransaction in Own Shares
10th May 202311:53 amRNSTransaction in Own Shares
9th May 20235:13 pmRNSTransaction in Own Shares
5th May 20239:21 amRNSTransaction in Own Shares
4th May 20232:14 pmRNSTransaction in Own Shares
4th May 20237:00 amRNSAcquisition
3rd May 202312:36 pmRNSTransaction in Own Shares
2nd May 20233:03 pmRNSTransaction in Own Shares
2nd May 20233:02 pmRNSTotal Voting Rights
28th Apr 20233:29 pmRNSTransaction in Own Shares
27th Apr 20234:17 pmRNSTransaction in Own Shares
26th Apr 20235:01 pmRNSTransaction in Own Shares
25th Apr 20235:10 pmRNSTransaction in Own Shares
24th Apr 20235:09 pmRNSTransaction in Own Shares
24th Apr 20237:15 amRNSDirectorate Change
21st Apr 20235:45 pmRNSTransaction in Own Shares
20th Apr 20234:53 pmRNSTransaction in Own Shares
20th Apr 20237:00 amRNSTransaction in Own Shares
18th Apr 20235:14 pmRNSTransaction in Own Shares
17th Apr 20235:32 pmRNSTransaction in Own Shares
17th Apr 20235:26 pmRNSPublication of Annual Report and Accounts
14th Apr 20234:59 pmRNSTransaction in Own Shares
14th Apr 20237:00 amRNSTransaction in Own Shares
12th Apr 20235:25 pmRNSTransaction in Own Shares
12th Apr 20237:00 amRNSInvestor Presentation
11th Apr 20235:30 pmRNSTransaction in Own Shares
6th Apr 20235:24 pmRNSTransaction in Own Shares
5th Apr 20235:40 pmRNSTransaction in Own Shares
5th Apr 20239:56 amRNSClarification of dividend timeline
5th Apr 20237:00 amRNS2022 Full Year results
4th Apr 20235:20 pmRNSTransaction in Own Shares
3rd Apr 20235:42 pmRNSTransaction in Own Shares
3rd Apr 20235:40 pmRNSTotal Voting Rights
3rd Apr 20237:00 amRNSTransaction in Own Shares
30th Mar 20235:16 pmRNSTransaction in Own Shares
29th Mar 20235:45 pmRNSTransaction in Own Shares
28th Mar 20235:20 pmRNSTransaction in Own Shares
27th Mar 20235:30 pmRNSTransaction in Own Shares
24th Mar 20234:51 pmRNSTransaction in Own Shares
23rd Mar 20234:33 pmRNSTransaction in Own Shares
22nd Mar 20234:53 pmRNSTransaction in Own Shares
21st Mar 20234:36 pmRNSTransaction in Own Shares
20th Mar 20235:17 pmRNSTransaction in Own Shares
17th Mar 20234:57 pmRNSTransaction in Own Shares
16th Mar 20235:08 pmRNSTransaction in Own Shares
15th Mar 20235:48 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.